Amgen (AMGN) EBT (2009 - 2026)

Amgen has reported EBT for 18 years, with the latest figure at $2.8 billion in Q2 2026.

• On a quarterly basis, EBT rose 76.53% year-over-year to $2.8 billion in Q2 2026; TTM through Jun 2026 was $10.3 billion, a 38.56% increase from a year earlier, with the FY2025 full-year figure at $9.0 billion, up 94.75% from the prior year.
• EBT was $2.8 billion for Q2 2026 at Amgen, up from $2.1 billion in the prior quarter.
• The five-year high for EBT was $3.9 billion in Q3 2025, with the low at -$68.0 million in Q1 2024.
• Average EBT over 5 years is $1.9 billion, with a median of $1.7 billion recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: EBT plunged 101.98% in 2024, then soared 3001.47% in 2025.
• Over 5 years, EBT stood at $1.7 billion in 2022, then tumbled by 51.26% to $852.0 million in 2023, then dropped by 8.22% to $782.0 million in 2024, then jumped by 93.61% to $1.5 billion in 2025, then jumped by 82.83% to $2.8 billion in 2026.
• The last three EBT figures came in at $2.8 billion (Q2 2026), $2.1 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.